# ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT

> **NCT00378443** · NA · UNKNOWN · sponsor: **Peking University**

## Conditions studied

- Glomerulonephritis, IGA

## Interventions

- **DRUG:** prednisone + Inhibace/Cozaar
- **DRUG:** Inhibace/Cozaar

## Key facts

- **NCT ID:** NCT00378443
- **Lead sponsor:** Peking University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2006-01
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** — (—)
- **Last updated:** 2006-09-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00378443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00378443, "ACEi/ARB Alone Versus ACEi/ARB Plus Steroids in the Treatment of Primary IgA Nephropathy, a RCT". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00378443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*